FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is an 8 week research study of aripiprazole (abilify) which is used to reduce irritable
behaviors in autism spectrum disorders. All participants will receive active study
medication. Participants will also receive diagnostic and cognitive evaluations at no cost.
Participants will be required to undergo two fMRI (functional magnetic resonance imaging
scans) where we will take pictures of your brain while performing simple tasks.
Phase:
Phase 4
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Duke University National Institute of Mental Health (NIMH)